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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYOver the past years, microRNAs (miRNAs) have emerged as crucial factors that regulate self-renewal and differentiation of embryonic
stem cells (ESCs). Although much is known about their role in maintaining ESC pluripotency, the mechanisms by which they affect
cell fate decisions remain poorly understood. By performing deep sequencing to profile miRNA expression in mouse ESCs (mESCs)
and differentiated embryoid bodies (EBs), we identified four differentially expressed miRNAs. Among them, miR-191 and miR-16-1
are highly expressed in ESCs and repress Smad2, the most essential mediator of Activin-Nodal signaling, resulting in the inhibition of
mesendoderm formation. miR-23a, which is also down-regulated in the differentiated state, suppresses differentiation toward the endo-
derm and ectoderm lineages. We further identified miR-421 as a differentiation-associated regulator through the direct repression of the
core pluripotency transcription factor Oct4 and the bone morphogenetic protein (BMP)-signaling components, Smad5 and Id2. Collec-
tively, our findings uncover a regulatory network between the studied miRNAs and both branches of TGF-b/BMP-signaling pathways,
revealing their importance for ESC lineage decisions.INTRODUCTION
Embryonic stem cells (ESCs), derived from pre-implanta-
tion embryos, share two unique properties: the ability to
grow indefinitely in culture and to differentiate into all
cell types (Evans and Kaufman, 1981). ESC self-renewal is
regulated by a complex network of transcription factors
and signaling pathways (Ng and Surani, 2011). The trans-
forming growth factor b (TGF-b) pathway plays a pivotal
role in cell fate determination during mouse embryonic
development, such as primitive streak formation (Oshi-
mori and Fuchs, 2012). Both Smad1/5/8 and Smad2/3
branches are involved in pluripotency and differentiation
of ESCs. Activin/Nodal/Smad2/3 signaling is important
for proper differentiation toward themesendoderm lineage
(Fei et al., 2010), whereas bone morphogenetic protein
(BMP)/Smad1/5/8 signaling promotes self-renewal in
mouse ESCs (mESCs) (Ying et al., 2003).
Accumulating evidence reveals thatmicroRNAs (miRNAs)
are crucial in controlling the pluripotent stem cell state.
Their important regulatory role in mouse and human ESCs
has been identified using Dicer and DGCR8 knockout
mice. Dicer and DGR8 deletion resulted in embryonic
lethality (Bernstein et al., 2003), while DGCR8-deficient
mESCs were viable but defective in proliferation and differ-
entiation (Wang et al., 2007). Several studies reported on
miRNAsmaintaining the ESC state,whereas others reported
miRNAs as promoting differentiation. miR-290–295 and
miR-302–367 clusters include the most abundant miRNAs
in mouse and human ESCs and are characterized as ES cell-292 Stem Cell Reports j Vol. 6 j 292–301 j March 8, 2016 j ª2016 The Authospecific cell cyclemiRNAs (Gangaraju andLin, 2009;Melton
etal., 2010). Incontrast,miR-134,miR-296, andmiR-470are
related to ESC differentiation and self-renewal silencing
(Tay et al., 2008). Although there is no doubt that miRNAs
regulate ESC self-renewal and lineage commitment, their
role in relevant signaling pathways that determine ESC
function remains unclear.
In this study, we report the identification of four miRNAs
as critical regulators of ESC fate. miR-16-1 (miR-16-1/15a
cluster) and miR-191 (miR-191/425 cluster), which are
highly expressed in mESCs, directly target Smad2, an
Activin/Nodal signaling important mediator, leading to
the inhibition of mesendoderm lineage. Another miRNA
expressed in the undifferentiated state, miR-23a (miR-27/
24a/23a cluster), inhibits the endodermal and ectodermal
differentiation. On the contrary, miR-421 (miR-421/374b/
c cluster) was identified as a differentiation regulator, by
suppressing BMP signaling and the critical pluripotency
factor, Oct4. Altogether, the mechanisms incorporating
the two branches of TGF-b signaling pathway and miRNAs
are highlighted, unraveling their importance to ESC line-
age commitment.RESULTS AND DISCUSSION
GlobalmiRNAAnalysis ofmESCs andDay-8 Embryoid
Bodies
To identify miRNAs pivotal for ESC function and biology,
we performed a global miRNA analysis from mESCs andrs
Figure 1. miRNA Profiling of mESCs and
Differentiated Cells
(A) Heatmap of log2-transformed miRNA
abundances in replicate samples of undif-
ferentiated ESCs and differentiated cells
(EBs D8).
(B) Venn diagram showing common miRNAs
between 59 stem cell-related miRNAs based
on literature compiled from miRbase, our
32 down- and 29 up-regulated miRNAs, and
107 miRNAs whose mRNA targets were
found to be significantly deregulated be-
tween days 0 and 9 in an independent
study. Short lists of primary miRNA candi-
dates for down- and up-regulated species
are included.
(C) The RT-PCR verification of the four
selected miRNA levels. Data are shown
as mean ± SD of three independent ex-
periments.day-8 embryoid bodies (EBs D8). Although the analysis
revealed a large number (442) of differentially expressed
miRNAs (Table S1), we restricted it by narrowing it down
to highly abundant miRNAs. Thus, a total of 61 miRNAs
with high abundance at either time point (D0 or D8) was
further analyzed in terms of relative expression, relation-
ship to the developmental process, and expression of their
target genes. Of the 61 differentially expressed miRNAs,
32 were down- and 29 were up-regulated at D8, with
this behavior being fairly consistent between replicates
(Figure 1A). Among them, well-studied miRNAs crucial
for pluripotent state were identified, such as miR-290–295
and miR-302 clusters (Gangaraju and Lin, 2009; Melton
et al., 2010). In addition, those 61 miRNAs overlapped
with previous published data for ESCs and EBs D5 or D7
(Table S2) (Lewis et al., 2005; Lee et al., 2011).
Screening the literature formousemiRNAs (miRBase, Rel.
21), a list of 59miRNAs reported to be implicated in the ESC
differentiation process (Kozomara and Griffiths-Jones,
2014) was obtained (Table S3). Comparing the above list
with our deregulated miRNAs, 43% of them were identical
(26 of 61). However, we focused on the remaining miRNAs
(57%), which have not been previously involved in ESC
identity (Table S3).
Following a different approach, we performed a com-
bination of in silico target analysis coupled with gene-
expression data. Predicted miRanda (Betel et al., 2008)
and TargetScan (Lewis et al., 2005) miRNA targets were
gathered to form a concise table of genes targeted by our
differentially expressed miRNAs. We obtained expressionStemvalues of mRNA genes from a genome-wide expression
profiling of mESC differentiation (Hailesellasse Sene et al.,
2007). Scanning the list of all miRNA measured in our
study, we obtained the mean log (fold change) of mRNA
expression between D9 and D0 in the aforementioned
study. By comparing this value for each of the miRNA
targets with the overall mean of expression change, we
pinned down 106miRNAs whose targets were significantly
deregulated during differentiation. The intersection of
these 106 miRNAs with our deregulated ones, not reported
to be related to stem cell differentiation, led to two short
lists containing three up-regulated and six down-regulated
miRNAs (Figure 1B). After further searching the literature
for the predicted targets of selected miRNAs and following
validation of the expression level changes, we ended up
with four miRNAs. miR-16-1, miR-191, and miR-23a are
down-regulated upon differentiation, whereas miR-421 is
up-regulated in EBs D8 (Figure 1C).
miR-16-1 and miR-191 Inhibit Mesendoderm
Differentiation by Targeting Activin/Smad2 Signaling
Pathway
To evaluate the functional role of miR-16-1 andmiR-191 in
mESCs we usedmiR-16-1, miR-191 inhibitors, or miR-16-1,
miR-191mimics (Figure 2A), and examined their impact on
self-renewal and pluripotency. Neither the inhibition nor
the overexpression of these miRNAs caused any changes
at the expression levels of Oct4 and Nanog (Figure S1A). In
addition, no effect onmESCmorphology (data not shown)
and cell cycle (Figure S1B) was observed. These data suggestCell Reports j Vol. 6 j 292–301 j March 8, 2016 j ª2016 The Authors 293
that miR-191 and miR-16-1 do not play a crucial role in
mESC self-renewal.
We next examined the potential effect of miR-191 and
miR-16-1 on the induction of differentiation markers in
the undifferentiated state. We found that after 72 hr of
their inhibition, characteristic endodermal (Gata4, Gata6)
andmesodermal (T,Gsc, Lhx1, Bmp4) markers were slightly
up-regulated, whereas ectodermal (Pax6, Sox1) markers did
not seem to be affected (Figure S1C). Conversely, miR-16-1
andmiR-191 overexpression did not exert changes on line-
age markers compared with negative control mimic (data
not shown).
To study the mechanism by which these miRNAs regu-
late mESC differentiation, we focused on their targets.
Smad2 mRNA is predicted to have binding sites for
miR-16-1 and miR-191 (Figure 2B). Since it is known that
Activin/Smad2 signaling is crucial formesoderm and endo-
derm development in vivo (Moustakas and Heldin, 2009)
and mESC differentiation in vitro (Fei et al., 2010), we
hypothesized that miR-16-1 and miR-191 may compete
with Activin/Smad2 signaling. To analyze whether Smad2
is a direct target of these miRNAs, we performed luciferase
reporter assays using constructs that harbor wild-type (WT)
or mutant (MUT) 30 UTR of Smad2. We found that either
miR-191 or miR-16-1 suppressed the WT but not MUT 30
UTR reporter activity, and a combination of both miRNAs
led to higher levels of suppression (Figure 2C).
To examine whether miR-16-1 and miR-191 interfere
with Activin/Smad2 signaling, we employed the Activin
Response Element reporter (pARE-Lux) in mESCs and
analyzed the effect of a mixture of miR-16-1/miR-191
mimics on the activity upon stimulation with 25 ng/ml ac-
tivin A. Whereas activin A enhanced the reporter activity,
simultaneous addition of 10 mM SB431542 (an inhibitor
of activin receptors) abolished the effect. Interestingly,
the combined miR-16-1/miR-191 mimics inhibited the
activation of the reporter by 47% (Figure 2D). To further
confirm that miR-16-1 and miR-191 influenced Activin/
Smad2 signaling, we examined the effect on SMAD2 and
p-SMAD2 protein levels. miR-16-1/miR-191 knockdown
mESCs had higher levels of SMAD2 and p-SMAD2, while
mESCs transfected with miR-16-1/miR-191 mimics ex-
hibited lower levels compared with controls (Figure 2E).
These data reinforced the hypothesis that miR-16-1 and
miR-191 diminish the activity of Activin/Smad2 signaling
through Smad2 downregulation.
To examine whether the aforementioned miRNAs affect
the mESC differentiation program, we transfected mESCs
with a mixture of miR inhibitors or mimics and induced
them to differentiate. As a control, mESCs treated with
activin A or SB431542 was used. The efficiency of miR-
16-1, miR-191 knockdown or overexpression (Figure S1D),
as well as the expression of several lineage markers, was294 Stem Cell Reports j Vol. 6 j 292–301 j March 8, 2016 j ª2016 The Authomeasured at EBs D0, D4, and D8. The induction of meso-
dermal (T, Gsc) and endodermal (Gata4, Gata6) markers
were up-regulated upon inhibition of miR-16-1 and
miR-191 (Figure 2F). Activin A caused an increase of meso-
dermal markers (T, Gsc) and the endodermal marker Gata4
while Gata6 was not affected, in line with previously
published data (Lee et al., 2011). The significant increase
of Gata6 induction by the addition of miR inhibitors may
be attributed to Smad2 up-regulation (Fei et al., 2010). In
contrast, the Sox1 ectodermal marker showed no signifi-
cant changes (Figure 2F). Conversely, miR mimics reduced
endoderm andmesoderm induction, similarly to the activ-
ity of SB431542 (Figure 2G). Contrary to miR mimics,
SB431542 increases Gata6 induction (Lee et al., 2011).
Interestingly, due to the alteration of Smad2 expression
levels, the induction of trophectoderm marker (Cdx2) was
significantly elevated by the miR inhibitors and lowered
by the miR mimics (Figures 2F and 2G), while it remained
unaffected by activin A and SB431542 (Fei et al., 2010;
Lee et al., 2011).
Based on the above data, we conclude that miR-191 and
miR-16-1 repress mesendoderm differentiation of mESCs
through direct targeting of Smad2 and subsequent post-
transcriptional control of Activin/Nodal signaling. In
different settings, miR-16-1 and miR-191 are reported to
regulate cell proliferation and/or cell cycle. In detail,
miR-191 acts mainly as an oncomiR, but can also serve as
a tumor suppressor (Nagpal and Kulshreshtha, 2014).
miR-16-1 has a well-defined tumor-suppressor and cell cy-
cle-arresting role in leukemia (Pekarsky and Croce, 2015).
Our data revealed that these miRNAs did not affect the
ESC cell cycle, and this difference may be attributed to
the peculiar ESC cell cycle profile. It would be interesting
to investigate whether Activin signaling is also involved
in the tumor-regulatory functions of these miRNAs.
miR-23a Represses Ectoderm and Endoderm
Differentiation of mESCs
To gain insights into the potential role of miR-23a in
mESCs, we used an miR-23a inhibitor and an miR-23a
mimic (Figure 3A). To assess the influence of miR-23a on
mESC self-renewal, we analyzed the expression levels of
stemness markers (Oct4, Nanog, Nr0b1) in mESCs trans-
fected with miR-23a inhibitor or mimic, but no difference
compared with the controls was observed (Figures S2A
and S2B). Furthermore, miR-23a inhibition or overexpres-
sion did not cause any changes in mESC morphology
(data not shown) or cell cycle (Figure S2C).
Following in silico research, we identified three differen-
tiation markers, Afp, Sox17, and Islet1, that were predicted
to be targets of miR-23a (Figure 3B). Indeed, compared
with controls, their protein and mRNA expression levels
were induced in mESCs transfected with miR-23a inhibitorrs
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Figure 2. miR-16-1 and miR-191 Antagonize Activin/Smad2 Signaling in mESCs and Repress Mesendoderm Differentiation
(A) Measurement of miR-16-1 and miR-191 levels by RT-PCR after transient transfection with miR mimics or inhibitors. Error bars indicate
SD of three independent experiments.
(B) miR-16-1 and miR-191 target sites in the 30 UTR of Smad2. Red indicates complementarity between miRNA and the target gene. Error
bars indicate SD of three independent experiments.
(legend continued on next page)
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(Figures 3C and 3D), while remained constant in over-
expressing miR-23a mESCs (Figure S2D). Next, through
a luciferase reporter assay, we verified the direct link
between miR-23a and the three differentiation markers.
To verify the specificity of miR-23a binding to Sox17,
we used a mutated 30 UTR (Figure 3E). In addition, two
endodermal (Gata6, Gata4) and three ectodermal (Pax6,
Sox1, Fgf5) markers were up-regulated 72 hr after miR-
23a inhibition (Figure S2E), whereas no effect was detected
on their levels in miR-23a mimic-transfected mESCs
(Figure S2F).
Sox17 has been previously reported to drive the up-
regulation of the primitive endoderm-associated program,
giving rise to endodermal progenitors (Niakan et al.,
2010). The suppression of Sox17 and Afp, another endo-
derm marker gene, by miR-23a reinforces the hypothesis
that miR-23a inhibits differentiation toward this lineage.
To test this assumption, we allowed mESCs transfected
by miR-23a inhibitor or mimic to differentiate as EBs.
miR-23a inhibition or overexpression was verified on EBs
D0, D4, and D8 (Figure S2G). A significant increase in
the induction of endodermal (Afp, Sox17, Gata6, Gata4)
and ectodermal (Islet1, Fgf5, Sox1) genes was observed (Fig-
ure 3F) upon miR-23a inhibition, whereas trophectoderm
and mesoderm lineage markers were not affected (Fig-
ure S2H). Interestingly, in miR-23a overexpressing mESCs
the differentiation toward these lineages is suppressed,
suggesting that the expression level of miR-23a is critical
for pluripotency maintenance (Figure 3F).
The above results clearly show that miR-23a is an addi-
tional regulator of ESC differentiation. Recently, the miR-
23a/24-2/27a cluster has been reported to be regulated by
BMP4 and target Smad5 to protect mESCs from apoptosis
during the transition to epiblast stem cells (Musto et al.,
2014). In addition, miR-23a inhibits the osteoblast differ-
entiation by targeting Runx2 (Hassan et al., 2010). In line
with these observations, our results strongly support that
miR-23a is a pivotal regulator of differentiation and con-
trols ESC-specific germ-layer commitment and subsequent
lineage decisions.
With respect to cancer, miR-23a has been considered
either as an oncomiR (Chhabra et al., 2010) or a tumor
suppressor (He et al., 2014). Apoptosis, migration, and in-
vasion are some of its effects in cancer through regulation
of molecular targets (PTEN, DAPP), while TGF-b/BMP has(C) miR-16-1 and miR-191 specifically repress their target in the lu
experiments. *p < 0.05 **p < 0.01.
(D) Ectopic expression of miR-16-1/miR-191 inhibits ARE-luc activity.
0.05 **p < 0.01.
(E) Total SMAD2 and p-SMAD2 protein levels detected.
(F and G) Relative mRNA levels of genes associated with the three ge
repression (F) or overexpression (G). Error bars indicate SD of three i
296 Stem Cell Reports j Vol. 6 j 292–301 j March 8, 2016 j ª2016 The Authobeen implicated in the control of miR-23a expression in
human cancers (Chandran et al., 2014).
In conclusion, miR-23a has a role in both tumor pro-
gression and mESC function, and the cross-regulatory
relationship with TGF-b/BMP signaling awaits further
investigation.
miR-421 Regulates Distinct Fate Choices of ESCs
through Oct4 Repression and Competition with BMP
Signaling
In contrast to the abovemiRNAs, miR-421 was identified as
a differentiation-associated regulator, and its expression
level was up-regulated during EB formation.
To study whether miR-421 is a crucial player in con-
trolling differentiation, we ectopically expressed miR-421
in mESCs by using its mimic (Figure 4A). Compared
with the control, miR-421 mimic had no effect on cell
morphology (data not shown) and cell cycle progression
(Figure S3A), but its addition significantly reduced the
Oct4 expression levels (Figure 4B) while other pluripotency
genes remained constant. Using bioinformatics tools
(Miranda, TargetScan), miR-421 was predicted to bind the
Oct4 30 UTR, and the direct link between the two
was further confirmed by luciferase reporter assay
(Figure 4C).
To test the effect of miR-421 overexpression on differen-
tiation, we analyzed the expression levels of several lineage
markers. Interestingly, the trophectodermmarkerCdx2was
up-regulated (Figure 4D), in agreement with previous
studies showing the repression of trophectoderm by Oct4
(Strumpf et al., 2005). Moreover, miR-421 overexpression
was accompanied by a slight induction of primitive endo-
derm markers (Gata4, Gata6, Afp), which is consistent
with previously published data analyzing the changes of
gene expression upon inhibition of Oct4 (Hay et al.,
2004; Strumpf et al., 2005). Interestingly, ectoderm-asso-
ciated markers (Pax6, Sox1) were also up-regulated (Fig-
ure 4D), indicating that miR-421 might exert its action
through an additional mechanism.
Due to the fact that several components of BMP signaling
were predicted as candidate targets of miR-421 (Bmpr1,
Smad5, Id2) (Figure 4E), we hypothesized that miR-421
may regulate this signaling and, thereby, lineage specifica-
tion. Since the BMP pathway plays an important role in
maintaining mESCs in the pluripotent state (Ying et al.,ciferase assay. Data are shown as mean ± SD of four independent
Data are shown as mean ± SD of four independent experiments. *p <
rm layers at EBs D0, D4, and D8 in response to miR-16-1/miR-191
ndependent experiments.
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2003), through the activation of Id proteins acting as
neuronal differentiation inhibitors (Ying et al., 2003;
Zhang et al., 2010), the effect of miR-421 on BMP activity
was investigated. Firstly, we confirmed that miR-421 over-
expression significantly repressed the luciferase activity of
the BRE-Luc reporter gene in response to BMP4 treatment
compared with control (Figure 4F). Overexpression of
miR-421 also reduced the mRNA expression levels of the
endogenous targets of BMP signaling Id1, Id2, and Id3
(Figure 4G).Moreover, a luciferase reporter assay confirmed
that miR-421 targeted directly the Id2 30 UTR (Figure 4H).
Interestingly, SMAD5 protein levels were decreased in
mESCs expressing miR-421 mimic (Figure 4I), while
Smad5 30 UTR reporter assays verified the direct regulation
of Smad5 by miR-421 (Figure 4J). To further analyze the
function of miR-421 in differentiation, we differentiated
mESCs transfected with miR-421 mimic or miR-421 inhib-
itor (Figure S3B). The overexpression of miR-421 favored
the suppression of Oct4 and at the same time enhanced
the induction of trophectoderm (Cdx2, Eomes) and endo-
derm (Gata4, Gata6) differentiation (Figure 4K). Concern-
ing the induction of ectodermal markers (Pax6, Sox1),
miR-421 elevation caused a significant increase, whereas
the addition of BMP4 did not allow differentiation toward
this lineage. miR-421 inhibitor up-regulated Oct4 expres-
sion and down-regulated the expression of trophecto-
derm, endoderm, and ectoderm differentiation markers
(Figures 4K and 4L). Moreover, mesodermal markers
(Flk1, Gsc) were not induced upon miR-421 overexpres-
sion, in contrast to miR-421 inhibition or BMP4 treatment
whereby their induction was significantly raised (FiguresFigure 4. miR-421 Induces Differentiation by Suppressing Oct4 a
(A) Measurement of miRNA levels by RT-PCR after transient transfectio
experiments.
(B) mRNA and protein levels of stemness factors (Oct4 and Nanog) a
pendent experiments.
(C) mir-421 target sites in the 30 UTR of Oct4. Luciferase activity of
complementarity between miRNA and the target gene. Data are show
(D) Relative mRNA levels of differentiation markers in miR-421-induc
(E) miR-421 binding sites in the 30 UTR of Smad5 and Id2. Red indic
(F) miR-421 overexpression inhibits BRE-Luc activity. Data are shown
(G) RT-PCR analysis of BMP4 target gene (Ids) expression levels in m
pendent experiments.
(H) Overexpression of miR-421 decreased the luciferase activity of Id
*p < 0.05.
(I and J) SMAD5 protein levels (I) and Smad5 30 UTR luciferase activity
four independent experiments. *p < 0.05.
(K) Relative mRNA levels of differentiation genes at EBs D0, D4, and D
of three independent experiments.
(L and M) Relative mRNA levels of ectodermal (L) and mesodermal (M
expression or inhibition in the presence of BMP4. Error bars indicate
(N) Proposed mechanism for the regulation of mESC differentiation b
Stem4M and S3C). In agreement with these data, the concurrent
addition ofmiR-421mimic andBMP4 did not affect the dif-
ferentiation induction. It is noteworthy that ectodermal
genes appeared to be decreased, while mesodermalmarkers
were significantly increased in BMP4/miR-421 inhibitor-
treated cells (Figures 4L, 4M, and S3C).
The above experimental results suggest that miR-421 is
a positive regulator of mESC differentiation through two
mechanisms, suppression of Oct4 and competition with
BMP signaling.
Contrary to its function in mESCs, miR-421 has been
previously characterized as an oncomiR in several cancers.
In neuroblastoma, miR-421 suppresses ataxia-telangiecta-
sia mutated uncoupling DNA damage from cell cycle check
points (Hu et al., 2010). In pancreatic tumor cells, miR-421
represses Smad4, which is critical for BMP signal trans-
duction, and represses its target gene Id3, promoting cell
proliferation and colony formation (Hao et al., 2011).
Therefore, miR-421 regulates Smad4-mediated signaling
pathways in cancer cells. In addition, miR-421 is regu-
lated by the TGF-b and BMP4 pathway in pulmonary
artery smooth muscle cells, via a conserved Smad binding
element (Marchand et al., 2012).
To conclude, this study unveils an miRNA-mediated
mechanism for miRNAs that regulate ESC fate decisions
(Figure 4N). Regarding miR-16-1, miR-191, and miR-421,
this effect is due to competition with TGF-b family
signaling. Inhibition of Activin/Nodal pathway by miR-
16-1 and miR-191 promotes mESC maintenance, whereas
competition of miR-421 with the BMP pathway results in
exit of mESCs from pluripotency and their commitmentnd Regulating BMP-Signaling Pathway
n with miR-421 mimic. Error bars indicate SD of three independent
fter miR-421 overexpression. Error bars indicate SD of three inde-
Oct4 30 UTR upon miR-421 mimic supplementation. Red indicates
n as mean ± SD of four independent experiments. *p < 0.05.
ed mESCs. Error bars indicate SD of three independent experiments.
ates complementarity between miRNA and the target gene.
as mean ± SD of four independent experiments. **p < 0.01.
iR-421 overexpressed mESCs. Error bars indicate SD of three inde-
2. Data are shown as mean ± SD of four independent experiments.
(J) were reduced by miR-421 mimic. Data are shown as mean ± SD of
8 upon miR-421 overexpression or inhibition. Error bars indicate SD
) differentiation genes at EBs D0, D4, and D8 upon miR-421 over-
SD of three independent experiments.
y the aforementioned miRNAs.
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to ectodermal fate. Conversely, miR-23a is itself regulated
by TGF-b/BMP. Taken together, our work reveals a recip-
rocal antagonism between the investigated miRNAs
and TGF-b signaling pathways in regulating ESC differenti-
ation (Figure 4M). Our findings link these miRNAs
with TGF-b/BMP signaling and may have implications
in cancer biology, as the TGF-b pathway is a critical
regulator of tumor growth, invasion, and metastasis
(Drabsch and ten Dijke, 2012). miRNAs that have a parallel
function in cancer and stem cells may be useful candidate
molecules to advance the basic knowledge and design
combinatorial strategies for cancer and cell replacement
therapies.EXPERIMENTAL PROCEDURES
Cell Culture
The murine feeder-independent ESC line CGR8 was cultured in
gelatin-coated flasks in Glasgow minimal essential medium
(Gibco) supplemented with 500 U/ml leukaemia inhibitory factor
(LIF; ESGRO-Millipore), 2mML-glutamine (Gibco), 100 mM b-mer-
captoethanol (Gibco), and 15% heat-inactivated HyClone fetal
bovine serum (FBS; GEHealthcare Life Sciences). For EB formation,
cells were trypsinized and diluted in Iscove’s modified Dulbecco’s
medium (Gibco) supplemented with the above components, to a
final concentration of 1,000 cells/20 ml. EBs were cultured without
LIF as hanging drops for 2 days, then collected and cultured in
suspension for 6 more days.ACCESSION NUMBERS
The accessionnumber for small RNA-sequencing data stated in this
report is GEO: GSE76375.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, three figures, and three tables and can be found
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